Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Redx Oncology
Biotech
AstraZeneca drops GOLDILOX and the porcupine in R&D update
The drugmaker axed a cardiovascular disease prospect while stopping work on early-stage assets bought in from Ionis and Redx Pharma.
Nick Paul Taylor
Apr 25, 2024 3:24am
Jazz jumps into KRAS G12D space via $10M upfront deal with Redx
Feb 7, 2024 8:30am
Jounce jilts Redx for Concentra's surprise merger offer
Mar 27, 2023 10:56am
Biotech makes surprise bid to snatch Jounce out of Redx's hands
Mar 15, 2023 8:48am
Redx stung by porcupine inhibitor flop in biliary tract cancer
Mar 8, 2023 10:30am
Jounce lays off 57% of staff, agrees reverse merger with Redx
Feb 23, 2023 8:00am
